Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA099526-02
Application #
6698828
Study Section
Special Emphasis Panel (ZRG1-ET-1 (02))
Program Officer
Perry, Mary Ellen
Project Start
2003-02-01
Project End
2008-01-31
Budget Start
2004-02-01
Budget End
2005-01-31
Support Year
2
Fiscal Year
2004
Total Cost
$335,975
Indirect Cost

  Institution

Name
University of Texas MD Anderson Cancer Center
Department
Internal Medicine/Medicine
Type
Organized Research Units
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030

  Publications

Kiguchi, Kaoru; Ruffino, Lynnsie; Kawamoto, Toru et al. (2007) Therapeutic effect of CS-706, a specific cyclooxygenase-2 inhibitor, on gallbladder carcinoma in BK5.ErbB-2 mice. Mol Cancer Ther 6:1709-17
Wu, Qi; Kiguchi, Kaoru; Kawamoto, Toru et al. (2007) Therapeutic effect of rapamycin on gallbladder cancer in a transgenic mouse model. Cancer Res 67:3794-800
Wu, Qi; Gaddis, Sara S; MacLeod, Michael C et al. (2007) High-affinity triplex-forming oligonucleotide target sequences in mammalian genomes. Mol Carcinog 46:15-23
Kiguchi, Kaoru; Ruffino, Lynnsie; Kawamoto, Toru et al. (2005) Chemopreventive and therapeutic efficacy of orally active tyrosine kinase inhibitors in a transgenic mouse model of gallbladder carcinoma. Clin Cancer Res 11:5572-80